United Health Products, Inc. (UEEC) stock
Close on Oct 19, 2026Market cap $10.25MP/E –Yield –
United Health Products, Inc. reported revenue of $0 for the twelve months to Sep 30, 2026. At the latest close the market valued the company at $10.25M.
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Sep 30, 2026
Valuation
- Market cap
- $10.25M
- P/E ratio
- –
- Price to sales
- –
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Revenue
- $0
- Net income
- -$1.30M
- EPS, diluted
- $0.00
- Book value per share
- -$0.02
- Diluted shares
- 263M
Trading
- Previous close
- $0.05
- Open
- $0.05
- Day's range
- $0.04 – $0.05
- Volume
- 277,990
- Average volume (20 days)
- 60,244
Market cap history
Month-end market cap since 2011, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Oct 19, 2026. The S&P 500 is measured by the SPY fund.
| Period | UEEC | S&P 500 | Difference | UEEC per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | +16.8% | +0.6% | +16.1 pts | ||
| 3 months | -24.3% | +3.4% | −27.6 pts | ||
| Year to date | -28.6% | +13.3% | −41.8 pts | ||
| 1 year | -33.3% | +16.6% | −49.9 pts | ||
| 3 years | -86.1% | +86.4% | −172.4 pts | -48.2% | +23.1% |
| 5 years | -95.8% | +81.9% | −177.7 pts | -47.0% | +12.7% |
| 10 years | -54.1% | +318.9% | −373.0 pts | -7.5% | +15.4% |
Fifteen years at a glance
Fiscal years 2011 to 2025 and trailing twelve months, USD
Revenue
Gross profit
Operating income
Net income
EPS, diluted
Free cash flow
Press releases
Releases United Health Products filed with the SEC as exhibits to Form 8-K or 6-K
- News
- News
- News
- News
- News
- Update
About United Health Products
Orthopedic, Prosthetic & Surgical Appliances & Supplies
United Health Products, Inc. develops, manufactures, and markets hemostatic gauze for healthcare and wound care applications. Its primary product is CelluSTAT, a cotton-derived gauze that absorbs wound exudate and helps control bleeding. The company targets human surgical and wound care segments, including external trauma and internal surgical procedures. Its potential customer base includes hospitals, surgery centers, outpatient clinics, emergency medical services, and military medical providers. It also identifies hemodialysis centers, nursing homes, dental offices, and veterinary clinics as prospective clients.
Company profile, executives and historyUnited Health Products stock: common questions
What is United Health Products's stock price?
UEEC closed at $0.04 on Oct 19, 2026, down 23.53% on the day.
What is United Health Products's market cap?
United Health Products was worth $10.25M at the close on Oct 19, 2026: the share price times the diluted shares outstanding.
What is UEEC's P/E ratio?
United Health Products lost money over the twelve months to Sep 30, 2026 (diluted EPS $0.00), so it has no meaningful P/E ratio.
How much revenue does United Health Products make?
United Health Products reported revenue of $0 for the twelve months to Sep 30, 2026.
Does United Health Products pay a dividend?
No. United Health Products has not paid a cash dividend over the last twelve months.
How has UEEC stock performed over the past year?
Including dividends, UEEC returned -33.3% over the past year, against +16.6% for the S&P 500.
Who are United Health Products's competitors?
Companies most similar to United Health Products by business, industry and size include SMTI, CUPR, FEED, MDXG, ZJYL.
See a number that looks wrong?